A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years

NCT04921111 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

HPV Infection Vaccine Safety SCT1000

Interventions

DRUG: SCT1000
DRUG: Gardasil®9
DRUG: placebo
DRUG: Gardasil®

Sponsor

Sinocelltech Ltd.